Andrew Muratore active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TRILLIUM THERAPEUTICS | Director/Board Member | 2021-11-16 | - |
| Corporate Officer/Principal | 2021-11-16 | - |
Career history of Andrew Muratore
Statistics
International
| Canada | 2 |
Operational
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
- Stock Market
- Insiders
- Andrew Muratore
- Experience
